Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Shigenori Tadokoro"'
Autor:
Hiroshi Yamanaka, Masaomi Iyo, Tsuyoshi Sasaki, Yasutaka Fujita, Takahisa Saiga, Takeshi Simoyama, Shingo Noda, Hitoshi Suzuki, Shigenori Tadokoro, Nobuhisa Kanahara, Satoshi Yanahashi, Masanori Honma, Naoya Komatsu, Masayuki Takase
Publikováno v:
International clinical psychopharmacology. 35(6)
Dopamine supersensitivity psychosis (DSP) in patients with schizophrenia is induced by treatment with a high dosage of antipsychotics for a long time period, and it is characterized by unstable psychotic symptoms. The upregulation of dopamine D2 rece
Autor:
Takuya Ogata, Shigenori Tadokoro, Hiromi Motomura, Nobumasa Hayase, Jun Miura, Jun Itahashi, Maiko Machida, Haruki Sasaki, Kaori Yama
Publikováno v:
Proceedings for Annual Meeting of The Japanese Pharmacological Society. :PO3-14
Publikováno v:
Clinical Psychopharmacology and Neuroscience
Dopamine supersensitivity psychosis (DSP) is a type of acute exacerbation of recurrent psychosis caused by long-term treatment with antipsychotics in schizophrenic patients. Although DSP is exceedingly troublesome for clinicians, effective treatment
Autor:
Shigenori Tadokoro1,2 tadokoroshigenori@gmail.com, Naho Nonomura1,3, Nobuhisa Kanahara4, Kenji Hashimoto5, Masaomi Iyo1
Publikováno v:
Clinical Psychopharmacology & Neuroscience. 2017, Vol. 15 Issue 1, p79-81. 3p.
Autor:
Kenji Hashimoto, Yukihiko Shirayama, Hiroyuki Watanabe, Yasunori Oda, Shigenori Tadokoro, Nobuhisa Kanahara, Masayuki Takase, Masaomi Iyo
Publikováno v:
Journal of Psychopharmacology. 29:1308-1313
In humans, long-term antipsychotic treatment is known to induce movement disorders and a psychosis, called dopamine supersensitivity psychosis (DSP). The mechanism by which chronic administration of antipsychotic(s) causes DSP may be the treatment-in
Autor:
Shigenori, Tadokoro
Publikováno v:
Nihon rinsho. Japanese journal of clinical medicine. 71(4)
Aripiprazole (ARI) is one of atypical antipsychotics used for the treatment of schizophrenia all over the world, owing to its tolerability and ability to keep antipsychotic effect for an extended period of time. Its unique pharmacological feature, wh
Autor:
Tomihisa Niitsu, Hiroyuki Watanabe, Tasuku Hashimoto, Shigenori Tadokoro, Masaomi Iyo, Nobuhisa Kanahara, Kenji Hashimoto
Publikováno v:
Journal of clinical psychopharmacology. 33(3)
Several studies have proposed an optimal dopamine D2 receptor occupancy by antipsychotics (OOc) to establish optimal pharmacological treatment of schizophrenia. However, there are limitations to the use of the OOc, especially in application to patien
Autor:
Masaomi Iyo, Kenji Hashimoto, Naoe Okamura, Nobuhisa Kanahara, Shigenori Tadokoro, Yoshimoto Sekine
Publikováno v:
Schizophrenia Bulletin
Background: Long-term treatment of schizophrenia with antipsychotics is crucial for relapse prevention, but a prolonged blockade of D2 dopamine receptors may lead to the development of supersensitivity psychosis. We investigated the chronic effects o
Autor:
Katsumasa Muneoka, Kenji Hashimoto, Yukihiko Shirayama, Goro Fukami, Masaomi Iyo, Shigenori Tadokoro, Makoto Fukumoto
Publikováno v:
Hippocampus. 21(10)
Patients with depression showed a decrease in plasma and cerebrospinal fluid allopregnanolone (ALLO). But antidepressants increased the contents of ALLO in the rat brain. We examined the antidepressant-like effects of infusion of ALLO into the cerebr
Autor:
Yukihiko Shirayama, Katsumasa Muneoka, Hea Jin Ryu, Makoto Fukumoto, Shigenori Tadokoro, Goro Fukami, Kenji Hashimoto, Masaomi Iyo
Publikováno v:
Hippocampus. 23:544-544